Ability 0 7 0 7 O
to 8 10 8 10 O
have 11 15 11 15 O
CT 16 18 16 18 B-treatment
and/or 19 25 19 25 O
MRI 26 29 26 29 B-treatment
imaging 30 37 30 37 I-treatment
with 38 42 38 42 O
or 43 45 43 45 O
without 46 53 46 53 O
contrast 54 62 54 62 O
and 63 66 63 66 O
must 67 71 67 71 O
be 72 74 72 74 O
performed 75 84 75 84 O
within 85 91 85 91 O
120 92 95 92 95 B-upper_bound
days 96 100 96 100 I-upper_bound
prior 101 106 101 106 I-upper_bound
to 107 109 107 109 O
registration 110 122 110 122 O

Age 0 3 123 126 B-age
≥ 4 5 127 128 O
18 6 8 129 131 O
years 9 14 132 137 O
old 15 18 138 141 O
because 19 26 142 149 O
no 27 29 150 152 O
dosing 30 36 153 159 O
or 37 39 160 162 O
adverse 40 47 163 170 O
event 48 53 171 176 O
data 54 58 177 181 O
are 59 62 182 185 O
currently 63 72 186 195 O
available 73 82 196 205 O
on 83 85 206 208 O
the 86 89 209 212 O
use 90 93 213 216 O
of 94 96 217 219 O
Cyberknife 97 107 220 230 B-treatment
Radiosurgery 108 120 231 243 I-treatment
radiation 121 130 244 253 I-treatment
in 131 133 254 256 O
participants 134 146 257 269 O
< 147 148 270 271 O
18 148 150 271 273 O
years 151 156 274 279 O
of 157 159 280 282 O
age 160 163 283 286 B-age
, 163 164 286 287 O
children 165 173 288 296 O
are 174 177 297 300 O
excluded 178 186 301 309 O
from 187 191 310 314 O
this 192 196 315 319 O
study 197 202 320 325 O
but 203 206 326 329 O
will 207 211 330 334 O
be 212 214 335 337 O
eligible 215 223 338 346 O
for 224 227 347 350 O
future 228 234 351 357 O
pediatric 235 244 358 367 O
Phase 245 250 368 373 O
II 251 253 374 376 O
trials 254 260 377 383 O

At 0 2 384 386 O
least 3 8 387 392 O
12 9 11 393 395 B-upper_bound
month 12 17 396 401 I-upper_bound
life 18 22 402 406 B-clinical_variable
expectancy 23 33 407 417 I-clinical_variable

At 0 2 418 420 O
least 3 8 421 426 O
one 9 12 427 430 B-lower_bound
( 13 14 431 432 O
usually 14 21 432 439 O
up 22 24 440 442 O
to 25 27 443 445 O
3 28 29 446 447 B-upper_bound
) 29 30 447 448 I-upper_bound
gold 31 35 449 453 O
fiducial 36 44 454 462 O
placed 45 51 463 469 O
in 52 54 470 472 O
or 55 57 473 475 O
around 58 64 476 482 O
tumor 65 70 483 488 B-cancer
, 70 71 488 489 O
can 72 75 490 493 O
be 76 78 494 496 O
performed 79 88 497 506 O
on 89 91 507 509 O
the 92 95 510 513 O
same 96 100 514 518 O
day 101 104 519 522 O
- 105 106 523 524 O
after 107 112 525 530 O
signing 113 120 531 538 O
research 121 129 539 547 O
informed 130 138 548 556 O
consent 139 146 557 564 O

Decreased 0 9 565 574 O
platelet 10 18 575 583 B-clinical_variable
count 19 24 584 589 I-clinical_variable
and 25 28 590 593 O
/ 29 30 594 595 O
or 31 33 596 598 O
anticoagulation 34 49 599 614 B-treatment
parameters 50 60 615 625 O
that 61 65 626 630 O
would 66 71 631 636 O
preclude 72 80 637 645 O
transcutaneous 81 95 646 660 O
placement 96 105 661 670 O
of 106 108 671 673 O
fiducials 109 118 674 683 O

ECOG 0 4 684 688 B-clinical_variable
Performance 5 16 689 700 I-clinical_variable
Status 17 23 701 707 I-clinical_variable
≤2 24 26 708 710 O
( 27 28 711 712 O
Appendix 28 36 712 720 O
A 37 38 721 722 O
) 38 39 722 723 O

For 0 3 724 727 O
this 4 8 728 732 O
reason 9 15 733 739 O
and 16 19 740 743 O
because 20 27 744 751 O
Radiation 28 37 752 761 B-treatment
is 38 40 762 764 O
known 41 46 765 770 O
to 47 49 771 773 O
be 50 52 774 776 O
teratogenic 53 64 777 788 O
, 64 65 788 789 O
women 66 71 790 795 B-gender
of 72 74 796 798 O
child 75 80 799 804 O
- 80 81 804 805 O
bearing 81 88 805 812 O
potential 89 98 813 822 O
and 99 102 823 826 O
men 103 106 827 830 O
must 107 111 831 835 O
agree 112 117 836 841 B-contraception_consent
to 118 120 842 844 I-contraception_consent
use 121 124 845 848 I-contraception_consent
adequate 125 133 849 857 I-contraception_consent
contraception 134 147 858 871 I-contraception_consent
( 148 149 872 873 O
hormonal 149 157 873 881 B-contraception_consent
or 158 160 882 884 I-contraception_consent
barrier 161 168 885 892 I-contraception_consent
method 169 175 893 899 I-contraception_consent
of 176 178 900 902 I-contraception_consent
birth 179 184 903 908 I-contraception_consent
control 185 192 909 916 I-contraception_consent
; 192 193 916 917 O
abstinence 194 204 918 928 B-contraception_consent
) 204 205 928 929 O
prior 206 211 930 935 O
to 212 214 936 938 O
study 215 220 939 944 O
entry 221 226 945 950 O
and 227 230 951 954 O
for 231 234 955 958 O
the 235 238 959 962 O
duration 239 247 963 971 O
of 248 250 972 974 O
study 251 256 975 980 O
participation 257 270 981 994 O

Inability 0 9 995 1004 O
to 10 12 1005 1007 O
deliver 13 20 1008 1015 O
target 21 27 1016 1022 O
dose 28 32 1023 1027 O
with 33 37 1028 1032 O
CyberKnife 38 48 1033 1043 B-treatment
due 49 52 1044 1047 O
to 53 55 1048 1050 O
inability 56 65 1051 1060 O
to 66 68 1061 1063 O
image 69 74 1064 1069 O
fiducials 75 84 1070 1079 B-treatment

Inability 0 9 1080 1089 O
to 10 12 1090 1092 O
deliver 13 20 1093 1100 O
target 21 27 1101 1107 O
dose 28 32 1108 1112 O
with 33 37 1113 1117 O
CyberKnife 38 48 1118 1128 B-treatment
due 49 52 1129 1132 O
to 53 55 1133 1135 O
normal 56 62 1136 1142 O
tissue 63 69 1143 1149 O
dose 70 74 1150 1154 O
constraints 75 86 1155 1166 O

Inability 0 9 1167 1176 O
to 10 12 1177 1179 O
have 13 17 1180 1184 O
contrast 18 26 1185 1193 O
CT 27 29 1194 1196 B-treatment
or 30 32 1197 1199 O
MRI 33 36 1200 1203 B-treatment
to 37 39 1204 1206 O
help 40 44 1207 1211 O
define 45 51 1212 1218 O
tumor 52 57 1219 1224 B-cancer
volume 58 64 1225 1231 O
for 65 68 1232 1235 O
radiation 69 78 1236 1245 B-treatment
planning 79 87 1246 1254 I-treatment

Irreversible 0 12 1255 1267 O
coagulopathies 13 27 1268 1282 B-chronic_disease
that 28 32 1283 1287 O
preclude 33 41 1288 1296 O
fiducial 42 50 1297 1305 B-treatment
placement 51 60 1306 1315 I-treatment

Labs 0 4 1316 1320 O
: 4 5 1320 1321 O
Serum 6 11 1322 1327 B-clinical_variable
Creatinin 12 21 1328 1337 I-clinical_variable
<3 22 24 1338 1340 O
mg 25 27 1341 1343 I-upper_bound
/ 27 28 1343 1344 I-upper_bound
dl 28 30 1344 1346 I-upper_bound
, 30 31 1346 1347 O
Urinalysis 32 42 1348 1358 O
, 42 43 1358 1359 O
INR 44 47 1360 1363 B-clinical_variable
< 48 49 1364 1365 O
2 49 50 1365 1366 B-upper_bound
, 50 51 1366 1367 O
PTT 52 55 1368 1371 B-clinical_variable
< 56 57 1372 1373 O
70 57 59 1373 1375 B-upper_bound
sec 60 63 1376 1379 I-upper_bound
, 63 64 1379 1380 O
AST 65 68 1381 1384 B-clinical_variable
, 68 69 1384 1385 O
ALT 70 73 1386 1389 B-clinical_variable
≤2.5x 74 79 1390 1395 O
ULN 80 83 1396 1399 I-upper_bound
, 83 84 1399 1400 O
Abnormalities 85 98 1401 1414 B-chronic_disease
on 99 101 1415 1417 I-chronic_disease
urinalysis 102 112 1418 1428 I-chronic_disease
( 113 114 1429 1430 O
i.e. 114 118 1430 1434 O
proteinuria 119 130 1435 1446 B-chronic_disease
) 130 131 1446 1447 O
will 132 136 1448 1452 O
not 137 140 1453 1456 O
exclude 141 148 1457 1464 O
patients 149 157 1465 1473 O
from 158 162 1474 1478 O
participation 163 176 1479 1492 O
on 177 179 1493 1495 O
study 180 185 1496 1501 O

No 0 2 1502 1504 O
irreversible 3 15 1505 1517 O
coagulopathies 16 30 1518 1532 B-chronic_disease

No 0 2 1533 1535 O
other 3 8 1536 1541 O
cancer 9 15 1542 1548 B-cancer
in 16 18 1549 1551 O
previous 19 27 1552 1560 B-upper_bound
2 28 29 1561 1562 I-upper_bound
years 30 35 1563 1568 I-upper_bound
with 36 40 1569 1573 O
the 41 44 1574 1577 O
exception 45 54 1578 1587 O
of 55 57 1588 1590 O
non 58 61 1591 1594 B-cancer
- 61 62 1594 1595 I-cancer
invasive 62 70 1595 1603 I-cancer
skin 71 75 1604 1608 I-cancer
cancers 76 83 1609 1616 I-cancer

Participants 0 12 1617 1629 O
must 13 17 1630 1634 O
have 18 22 1635 1639 O
histologically 23 37 1640 1654 O
or 38 40 1655 1657 O
radiological 41 53 1658 1670 O
evidence 54 62 1671 1679 O
of 63 65 1680 1682 O
Stage 66 71 1683 1688 B-cancer
I 72 73 1689 1690 I-cancer
( 74 75 1691 1692 I-cancer
T1N0M0 75 81 1692 1698 I-cancer
) 81 82 1698 1699 I-cancer
renal 83 88 1700 1705 I-cancer
cell 89 93 1706 1710 I-cancer
carcinoma 94 103 1711 1720 I-cancer
with 104 108 1721 1725 O
a 109 110 1726 1727 O
size 111 115 1728 1732 B-clinical_variable
no 116 118 1733 1735 O
larger 119 125 1736 1742 O
than 126 130 1743 1747 O
8 131 132 1748 1749 B-upper_bound
cm 133 135 1750 1752 I-upper_bound
in 136 138 1753 1755 I-upper_bound
greatest 139 147 1756 1764 I-upper_bound
dimension 148 157 1765 1774 I-upper_bound
measured 158 166 1775 1783 O
by 167 169 1784 1786 O
MRI 170 173 1787 1790 B-treatment
or 174 176 1791 1793 O
CT 177 179 1794 1796 B-treatment
Scan 180 184 1797 1801 I-treatment

Prior 0 5 1802 1807 O
history 6 13 1808 1815 O
of 14 16 1816 1818 O
invasive 17 25 1819 1827 B-cancer
malignancy 26 36 1828 1838 I-cancer
within 37 43 1839 1845 O
the 44 47 1846 1849 O
last 48 52 1850 1854 B-upper_bound
2 53 54 1855 1856 I-upper_bound
years 55 60 1857 1862 I-upper_bound

Prior 0 5 1863 1868 B-treatment
upper 6 11 1869 1874 I-treatment
abdominal 12 21 1875 1884 I-treatment
external 22 30 1885 1893 I-treatment
beam 31 35 1894 1898 I-treatment
irradiation 36 47 1899 1910 I-treatment

Should 0 6 1911 1917 O
a 7 8 1918 1919 O
woman 9 14 1920 1925 B-gender
become 15 21 1926 1932 B-pregnancy
pregnant 22 30 1933 1941 I-pregnancy

suspect 0 7 1942 1949 B-pregnancy
she 8 11 1950 1953 I-pregnancy
is 12 14 1954 1956 I-pregnancy
pregnant 15 23 1957 1965 I-pregnancy
while 24 29 1966 1971 O
participating 30 43 1972 1985 O
in 44 46 1986 1988 O
this 47 51 1989 1993 O
study 52 57 1994 1999 O
, 57 58 1999 2000 O
she 59 62 2001 2004 O
should 63 69 2005 2011 O
inform 70 76 2012 2018 O
her 77 80 2019 2022 O
treating 81 89 2023 2031 O
physician 90 99 2032 2041 O
immediately 100 111 2042 2053 O

